| Cardiac implantable electronic device‐induced tricuspid regurgitation: Implications and management SP Murphy, J Lew, E Yucel, J Singh, T Mela Journal of Cardiovascular Electrophysiology 35 (5), 1017-1025, 2024 | | 2024 |
| Isovolumic contraction velocity in heart failure with reduced ejection fraction and effect of sacubitril/valsartan: the PROVE-HF study AMS Omar, S Murphy, GM Felker, I Piña, J Butler, Y Liu, R Mohebi, ... Journal of Cardiac Failure 30 (5), 653-665, 2024 | 1 | 2024 |
| Sex differences in coronary artery disease characteristics among patients with type 2 myocardial infarction C Lin, CP McCarthy, R Mohebi, Y Liu, R Blankstein, SP Murphy, ... JACC: Advances 3 (2), 100795, 2024 | 1 | 2024 |
| Right Ventricular–Pulmonary Arterial Coupling and All-Cause Mortality in Patients with Mitral Annular Calcification–Related Mitral Valve Dysfunction SP Murphy, S Deferm, E Yucel, SM Urbut, J Hung, JP Dal-Bianco, ... Journal of the American Society of Echocardiography, 2024 | | 2024 |
| Echocardiography in acute heart failure and cardiogenic shock SP Murphy, MH Picard Emergency Echocardiography, 53-66, 2023 | | 2023 |
| Sex Differences in Coronary Artery Disease Characteristics Among Patients With Type 2 Myocardial Infarction: Results From the Prospective DEFINE-Type 2 MI Study C Lin, CP McCarthy, R Mohebi, Y Liu, R Blankstein, C Rogers, S Hedgire, ... Circulation 148 (Suppl_1), A11776-A11776, 2023 | | 2023 |
| Hearing is Believing: A Case of a Ruptured Sinus of Valsalva Aneurysm SP Murphy, GA Suero-Abreu, AN Paine, DE Cameron, CP Learn, ... Circulation 148 (Suppl_1), A12143-A12143, 2023 | | 2023 |
| Coronary computed tomographic angiography with fractional flow reserve in patients with type 2 myocardial infarction CP McCarthy, SP Murphy, DK Amponsah, PK Rambarat, C Lin, Y Liu, ... Journal of the American College of Cardiology 82 (17), 1676-1687, 2023 | 5 | 2023 |
| Progress Toward Prognosis in Patients With Pulmonary Embolism SP Murphy, SM Urbut, DM Dudzinski Journal of the American Society of Echocardiography 36 (9), 941-944, 2023 | 1 | 2023 |
| Clinical profiling of end-stage heart failure with preserved ejection fraction: The National Readmission Database R Mohebi, Y Liu, SP Murphy, HK Gaggin, JL Januzzi Jr International Journal of Cardiology 378, 71-76, 2023 | | 2023 |
| INFLAMMATION ACROSS UNIVERSAL DEFINITION OF HEART FAILURE STAGES: RESULTS OF CASABLANCA STUDY R Mohebi, Y Liu, R Van Kimmenade, HK Gaggin, SP Murphy, ... Journal of the American College of Cardiology 81 (8_Supplement), 633-633, 2023 | | 2023 |
| DEFINING THE PREVALENCE AND CHARACTERISTICS OF CORONARY ARTERY DISEASE AMONG PATIENTS WITH TYPE 2 MYOCARDIAL INFARCTION USING CT-FFR (DEFINE TYPE 2 MI) CP McCarthy, SP Murphy, H Miksenas, D Amponsah, P Rambarat, ... Journal of the American College of Cardiology 81 (8_Supplement), 1124-1124, 2023 | 1 | 2023 |
| Reply: Increasing the Utilization of Sac/Val in Elderly HFrEF Patients Eligible for ARNI Treatment SP Murphy, JL Januzzi Heart Failure 11 (3), 372-373, 2023 | | 2023 |
| Inflammation across universal definition of heart failure stages: the CASABLANCA study R Mohebi, Y Liu, R van Kimmenade, HK Gaggin, SP Murphy, ... European Journal of Heart Failure 25 (2), 152-160, 2023 | 8 | 2023 |
| Abstract A57: Killing cancer with keto: Beta-hydroxybutyrate the main metabolite produced by a ketogenic diet acts as an endogenous histone deacetylase inhibitor to sensitize … S Murphy Cancer Immunology Research 10 (12_Supplement), A57-A57, 2022 | | 2022 |
| Killing cancer with keto: Beta-hydroxybutyrate the main metabolite produced by a ketogenic diet acts as an endogenous histone deacetylase inhibitor to sensitize immunotherapy … S Murphy CANCER IMMUNOLOGY RESEARCH 10 (12), 2022 | | 2022 |
| Biomarker prognostication across universal definition of heart failure stages R Mohebi, S Murphy, L Jackson, C McCarthy, A Abboud, G Murtagh, ... ESC Heart Failure 9 (6), 3876-3887, 2022 | 7 | 2022 |
| Pre-existing autoimmune disease increases the risk of cardiovascular and noncardiovascular events after immunotherapy C Lee, ZD Drobni, A Zafar, CA Gongora, DA Zlotoff, RM Alvi, J Taron, ... Cardio Oncology 4 (5), 660-669, 2022 | 13 | 2022 |
| Age differences in effects of sacubitril/valsartan on cardiac remodeling, biomarkers, and health status SP Murphy, JH Ward, IL Pina, GM Felker, J Butler, AS Maisel, X Meng, ... Heart Failure 10 (12), 976-988, 2022 | 5 | 2022 |
| Association between sacubitril/valsartan initiation and mitral regurgitation severity in heart failure with reduced ejection fraction: the PROVE-HF study JL Januzzi, AMS Omar, Y Liu, S Murphy, J Butler, GM Felker, IL Piña, ... Circulation 146 (21), 1638-1640, 2022 | 17 | 2022 |
